Abstract:Abstract Context The melanocortin-4 receptor (MC4R) plays an important role in body weight regulation. Pathogenic MC4R variants are the most common cause of monogenic obesity. Objective We have identified 17 MC4R variants in adult and pediatric patients with obesity. Here we aimed to functionally characterize these variants by analyzing 4 different aspects of MC4R signaling. In addition, we aimed to analyze the effect of setmelanotide, a potent MC4R agonist, on these MC4R variants. Materials and Methods Cell surface expression and α-melanocyte stimulating hormone (α-MSH)- or setmelanotide-induced cAMP response, β-arrestin-2 recruitment, and ERK activation were measured in cells expressing either wild type or variant MC4R. Results We found a large heterogeneity in the function of these variants. We identified variants with a loss of response for all studied MC4R signaling, variants with no cAMP accumulation or ERK activation but normal β-arrestin-2 recruitment, and variants with normal cAMP accumulation and ERK activation but decreased β-arrestin-2 recruitment, indicating disrupted desensitization and signaling mechanisms. Setmelanotide displayed a greater potency and similar efficacy as α-MSH and induced significantly increased maximal cAMP responses of several variants compared to α-MSH. Despite the heterogeneity in functional response, there was no apparent difference in the obesity phenotype in our patients. Conclusion We show that these obesity-associated MC4R variants affect MC4R signaling differently yet lead to a comparable clinical phenotype. Our results demonstrate the clinical importance of assessing the effect of MC4R variants on a range of molecular signaling mechanisms to determine their association with obesity, which may aid in improving personalized treatment.

What problem does this paper attempt to address?

This paper aims to address the obesity problems associated with MC4R (melanocortin - 4 receptor) mutations. Specifically, the researchers identified 17 MC4R mutations from obese adult and pediatric patients and functionally characterized these mutations by analyzing their impacts on four different aspects of MC4R signaling. These four aspects include: 1. **Cell - surface expression**: Evaluate the expression of MC4R variants on the cell membrane. 2. **α - MSH - or Setmelanotide - induced cAMP response**: Measure the cAMP accumulation of MC4R variants under the stimulation of α - MSH or Setmelanotide. 3. **β - arrestin - 2 recruitment**: Detect the influence of MC4R variants on β - arrestin - 2 recruitment. 4. **ERK activation**: Analyze the effect of MC4R variants on the activation of the ERK signaling pathway. In addition, the study also explored the impact of Setmelanotide (a potent MC4R agonist) on these MC4R variants. Through these experiments, the researchers hope to understand how these mutations affect the function of MC4R and whether Setmelanotide can improve the functional defects of certain mutations. ### Research background MC4R plays a crucial role in body weight regulation, and its loss - of - function (LoF) mutations are the most common cause of monogenic obesity. These mutations lead to symptoms such as early - onset obesity, hyperphagia, and insulin resistance. The researchers hope to better understand how these mutations affect MC4R signaling through functional characterization, thereby providing a basis for personalized treatment. ### Main findings - **Functional diversity**: The study found that these mutations show great heterogeneity in function. Some mutations completely lose all the studied MC4R signaling capabilities, while some mutations partially retain the functions of certain signaling pathways. - **Effect of Setmelanotide**: Setmelanotide shows higher potency and similar efficacy compared to α - MSH in most mutations. For some mutations, Setmelanotide can significantly increase the maximum cAMP response and even transform some completely loss - of - function mutations into partially loss - of - function ones. - **Consistency of clinical phenotypes**: Although these mutations show different functional impacts at the molecular level, the clinical phenotypes of patients (such as the degree of obesity) are relatively consistent. ### Conclusion The research results indicate that although these obesity - related MC4R mutations affect MC4R signaling in different ways at the molecular level, they ultimately lead to similar clinical phenotypes. These findings emphasize the importance of evaluating the impact of MC4R mutations on multiple molecular signaling mechanisms, which is helpful for improving the design of personalized treatment regimens.

MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels

Several Mutations in the Melanocortin 4 Receptor Gene Are Associated with Obesity in Chinese Children and Adolescents

Functional Characterization of Novel MC4R Variants Identified in Two Unrelated Patients with Morbid Obesity in Qatar

Obesity-associated MRAP2 variants impair multiple MC4R-mediated signaling pathways

Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor

Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment

Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways

Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R)

A Setmelanotide-like Effect at MC4R Is Achieved by MC4R Dimer Separation

Descriptive analysis of MC4R gene variants associated with obesity listed on ClinVar

Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor

The genetic epidemiology of melanocortin 4 receptor variants

MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency

A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice

Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach

Melanocortin 4 Receptors Reciprocally Regulate Sympathetic and Parasympathetic Preganglionic Neurons

Divergence of melanocortin pathways in the control of food intake and energy expenditure.

Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide

Do Common Variants Separate Between Obese Melanocortin-4 Receptor Gene Mutation Carriers and Non-Carriers? the Impact of Cryptic Relatedness.

The MRAP2 accessory protein directly interacts with melanocortin-3 receptor to enhance signaling

[Mutation Screening and Function Prediction of Melanocortin-4 Receptor Gene in Obese Children].